InvestorsHub Logo
Followers 0
Posts 51
Boards Moderated 0
Alias Born 07/15/2012

Re: None

Thursday, 02/07/2019 7:42:19 AM

Thursday, February 07, 2019 7:42:19 AM

Post# of 2495
CEO Khoso Baluch used to work for Eli Lilly before he went on to CorMedix to focus on the ultimate commercialization of Neutrolin--I'm sure he has many "contacts" at Eli Lilly who would love to form either a strategic partnership or "buyout" the company all together. The potential versatility of Neutrolin (nephrology, oncology, surgery (sutures etc) would make this a huge money maker for whoever works with them--I bet there is already an agreement contingent on the result of the upcoming FDA meeting
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CRMD News